[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3471 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 3471
To preempt States from establishing, implementing, or enforcing any ban
on the prescription, provision, or use of a drug, biological product,
or device for contraception if such drug, biological product, or device
is approved, licensed, cleared, or otherwise authorized for human use
by the Food and Drug Administration for contraception, and for other
purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
May 18, 2023
Mrs. Bice (for herself, Mrs. Kim of California, Mr. Smucker, Mr. Bacon,
Mrs. Miller-Meeks, and Mr. Graves of Louisiana) introduced the
following bill; which was referred to the Committee on Energy and
Commerce
_______________________________________________________________________
A BILL
To preempt States from establishing, implementing, or enforcing any ban
on the prescription, provision, or use of a drug, biological product,
or device for contraception if such drug, biological product, or device
is approved, licensed, cleared, or otherwise authorized for human use
by the Food and Drug Administration for contraception, and for other
purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Access to Safe Contraception Act of
2023''.
SEC. 2. PREEMPTION OF STATE BANS ON FDA-APPROVED PRODUCTS FOR
CONTRACEPTION.
(a) Preemption.--No State shall establish, implement, or enforce
any ban on the prescription, provision, or use of a drug, biological
product, or device for contraception if such drug, biological product,
or device is approved, licensed, cleared, or otherwise authorized for
human use by the Food and Drug Administration for contraception.
(b) Rules of Construction.--Nothing in subsection (a) shall be
construed--
(1) to infringe the ability of a State to regulate the
practice of medicine and pharmacy within such State;
(2) to preempt the Religious Freedom Restoration Act of
1993 (42 U.S.C. 2000bb et seq.); or
(3) to preempt any State law to the extent such State law
protects the right of any entity to opt out of providing
contraception if such provision would be contrary to that
entity's religious or moral beliefs.
(c) Definitions.--In this section:
(1) The term ``biological product'' has the meaning given
such term in section 351 of the Public Health Service Act (42
U.S.C. 262).
(2) The terms ``device'' and ``drug'' have the meanings
given such terms in section 201 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 321).
<all>